Bellevue Group Ag Acadia Pharmaceuticals Inc Transaction History

Bellevue Group Ag

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $1.04 Million - $1.63 Million	-65,900 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$25.02 - $54.99 $525,420 - $1.15 Million	21,000 Added 46.77%	65,900 $1.7 Million
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $113,854 - $152,917	2,900 Added 6.9%	44,900 $2.18 Million
Q1 2020 May 14, 2020	BUY	$31.65 - $46.87 $63,300 - $93,740	2,000 Added 5.0%	42,000 $1.78 Million
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $1.82 Million - $2.59 Million	-50,400 Reduced 55.75%	40,000 $1.71 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $297,748 - $589,734	-13,400 Reduced 12.91%	90,400 $3.25 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $129,360 - $219,040	8,000 Added 8.35%	103,800 $2.79 Million
Q4 2018 Feb 12, 2019	BUY	$14.32 - $22.92 $555,616 - $889,296	38,800 Added 68.07%	95,800 $1.55 Million
Q3 2018 Nov 13, 2018	BUY	$13.03 - $21.81 $742,710 - $1.24 Million	57,000 New	57,000 $1.18 Million
Q2 2018 Aug 07, 2018	SELL	$15.07 - $22.34 $520,668 - $771,847	-34,550 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$22.47 - $32.33 $11,235 - $16,165	-500 Reduced 1.43%	34,550 $776,000
Q4 2017 Feb 14, 2018	SELL	$26.84 - $39.14 $2.2 Million - $3.21 Million	-81,950 Reduced 70.04%	35,050 $1.06 Million
Q3 2017 Nov 13, 2017	SELL	$29.49 - $38.37 $2.03 Million - $2.65 Million	-69,000 Reduced 37.1%	117,000 $4.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	186,000	186,000 $5.85 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

Stay updated on Bellevue Group Ag with notifications on news.